Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Supportive Care in Cancer
Literature
1.
Ku PM, Waller JL, Sportes C, Clemmons AB (2018) Prolonged versus short infusion rates for intravenous magnesium sulfate administration in hematopoietic cell transplant patients. Support Care Cancer 26:2809–2814CrossRefPubMed
2.
Snyder M, Shillingburg A, Newton M, Hamadani M, Kanate AS, Craig M, Cumpston A (2016) Impact of intravenous magnesium infusion rate during ambulatory replacements on serum magnesium concentrations after allogeneic stem cell transplant. Support Care Cancer 24:4237–4240CrossRefPubMed
3.
Shechter M, Hod H, Chouraqui P, Kaplinsky E, Rabinowitz B (1995) Magnesium therapy in acute myocardial infarction when patients are not candidates for thrombolytic therapy. Am J Cardiol 75:321–323CrossRefPubMed
4.
Raghu C, Peddeswara Rao P, Seshagiri Rao D (1999) Protective effect of intravenous magnesium in acute myocardial infarction following thrombolytic therapy. Int J Cardiol 71:209–215CrossRefPubMed
5.
Rasmussen HS, McNair P, Norregard P, Backer V, Lindeneg O, Balslev S (1986) Intravenous magnesium in acute myocardial infarction. Lancet 1(8475):234–236CrossRefPubMed
6.
Woods KL, Fletcher S, Roffe C, Haider Y (1992) Intravenous magnesium sulphate in suspected acute myocardial infarction: results of the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2). Lancet 339:1553–1558CrossRefPubMed
7.
Furlanetto TW, Faulhaber GA (2011) Hypomagnesemia and proton pump inhibitors: below the tip of the iceberg. Arch Intern Med 171:1391–1392CrossRefPubMed
8.
Hamill-Ruth RJ, McGory R (1996) Magnesium repletion and its effect on potassium homeostasis in critically ill adults: results of a double-blind, randomized, controlled trial. Crit Care Med 24:38–45CrossRefPubMed
Metadata
Title
Factors influencing magnesium infusions in hematopoietic cell transplants
Authors
Michael S. Gin
Todd W. Canada
Publication date
01-06-2019
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 6/2019
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-019-04686-4

Other articles of this Issue 6/2019

Supportive Care in Cancer 6/2019 Go to the issue

Original Article

Spirituality and physical health status: a longitudinal examination of reciprocal effects in breast cancer survivors

Original Article

Caring for the person with cancer and the role of digital technology in supporting carers

Original Article

Design, implementation, and evaluation of an intervention to improve referral to smoking cessation services in breast cancer patients

Original Article

Prognostic evaluation in palliative care: final results from a prospective cohort study

Original Article

Optimizing cancer pain management in resource-limited settings

Original Article

Exercise improves functional capacity and lean body mass in patients with gastrointestinal cancer during chemotherapy: a single-blind RCT
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits